Table 1.
Clinicopathological characteristics of patients with non-muscle invasive bladder cancer (NMIBC), muscle invasive bladder cancer (MIBC) and normal urothelium (NU)
| NMIBC (%) | MIBC (%) | NU (%) | |
|---|---|---|---|
|
| |||
| n=186 | n=210 | n=51 | |
| Sex | |||
| Male | 150 (80.6) | 153 (72.9) | 29 (56.9) |
| Female | 36 (19.4) | 57 (27.1) | 22 (43.1) |
| Smoking status | |||
| Current | 43 (23.1) | 60 (28.6) | 1 (2) |
| Never | 78 (41.9) | 60 (28.6) | 5 (9.8) |
| Former | 9 (4.8) | 9 (4.3) | 6 (11.8) |
| Unknown | 55 (29.6) | 81 (38.6) | 45 (88.2) |
| Tumor stage | |||
| Ta | 101 (54.3) | 0 | n.a. |
| Tis | 33 (17.7) | 0 | n.a. |
| T1 | 52 (28.0) | 0 | n.a. |
| T2 | 0 | 77 (36.7) | n.a. |
| T3 | 0 | 96 (45.7) | n.a. |
| T4 | 0 | 37 (17.6) | n.a. |
| Grading | |||
| G1 | 62 (33.3) | 1 (0.5) | n.a. |
| G2 | 71 (38.7) | 59 (28.1) | n.a. |
| G3 | 49 (26.3) | 147 (70) | n.a. |
| G4 | 1 (0.5) | 1 (0.5) | n.a. |
| n.a. | 2 (1) | ||
| Lymph node metastasis | |||
| pN0 | 160 (86) | 103 (59) | n.a. |
| pN+ | 1 (0.5) | 69 (32.9) | n.a. |
| pNx | 38 (18.1) | n.a. | |
| Distant metastasis | |||
| M0 | 150 (80.6) | 119 (56.7) | n.a. |
| M1 | 0 (0) | 5 (2.4) | n.a. |
| n.a. | 36 (19.4) | 86 (41.0) | n.a. |
| Age | |||
| Mean | 67.01 | 67.72 | 65.96 |
| Median | 67 | 69 | 66 |
| Range | 30-92 | 38-94 | 43-84 |
Abbreviations: NMIBC=non-muscle invasive bladder cancer; MIBC=muscle invasive bladder cancer; NU=normal urothelium; n.a.=not applicable.